Abstract:This review outlines the evolutionary journey from traditional two-dimensional (2D) cell culture to the revolutionary field of organ-on-a-chip technology. Organ-on-a-chip technology integrates microfluidic systems to mimic the complex physiological environments of human organs, surpassing the limitations of conventional 2D cultures. This evolution has opened new possibilities for understanding cell–cell interactions, cellular responses, drug screening, and disease modeling. However, the design and manufacture of microchips significantly influence their functionality, reliability, and applicability to different biomedical applications. Therefore, it is important to carefully consider design parameters, including the number of channels (single, double, or multi-channels), the channel shape, and the biological context. Simultaneously, the selection of appropriate materials compatible with the cells and fabrication methods optimize the chips' capabilities for specific applications, mitigating some disadvantages associated with these systems. Furthermore, the success of organ-on-a-chip platforms greatly depends on the careful selection and utilization of cell resources. Advances in stem cell technology and tissue engineering have contributed to the availability of diverse cell sources, facilitating the development of more accurate and reliable organ-on-a-chip models. In conclusion, a holistic perspective of in vitro cellular modeling is provided, highlighting the integration of microfluidic technology and meticulous chip design, which play a pivotal role in replicating organ-specific microenvironments. At the same time, the sensible use of cell resources ensures the fidelity and applicability of these innovative platforms in several biomedical applications.

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are the limitations of traditional two - dimensional (2D) cell culture models and animal models in biomedical research. Specifically, these problems include: 1. **Inability to accurately simulate the human physiological environment**: Traditional 2D cell culture and animal models are difficult to fully reproduce the complex cell - cell, cell - matrix interactions and organ - specific microenvironments in the human body. 2. **Inefficiency in drug screening and disease modeling**: Due to the above limitations, these models have problems with insufficient predictive ability in drug screening and disease modeling, resulting in long new drug development cycles, high costs and low success rates. 3. **Challenges in cell resource and microenvironment control**: How to select appropriate cell resources and optimize the design parameters of microfluidic chips (such as the number and shape of channels, etc.) to better simulate in - vivo conditions is an urgent problem to be solved at present. For this reason, the paper explores the progress from traditional 2D cell culture to organ - on - a - chip (OoaC) technology, especially the application of microfluidic technology and design concepts in this field. OoaC overcomes the limitations of traditional 2D culture by integrating a microfluidic system to simulate the complex physiological environment of human organs, providing new possibilities for understanding cell - cell interactions, cell responses, drug screening and disease modeling. In addition, the paper also emphasizes the importance of the following aspects: - **Material selection and manufacturing methods**: Selecting materials compatible with cells and adopting appropriate manufacturing methods can optimize the function of the chip and reduce the disadvantages of these systems. - **Rational use of cell resources**: Advances in stem cell technology and tissue engineering technology make more diverse cell sources possible, which helps to develop more accurate and reliable OoaC models. In summary, this review aims to provide a comprehensive perspective, showing the crucial role of microfluidic technology and carefully designed chips in replicating organ - specific microenvironments, while ensuring the fidelity and applicability of these innovative platforms in various biomedical applications.

Organ-on-a-Chip: Ubi sumus? Fundamentals and Design Aspects

A Comprehensive Review of Organ-on-a-Chip Technology and Its Applications

Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization

Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases

From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications

Organ-on-a-chip: A new tool for in vitro research

Organ-on-Chip Approaches for Intestinal 3D In Vitro Modeling

Organ-On-a-Chip devices: Technology Progress and Challenges

Integrating organoids and organ-on-a-chip devices

Towards single-cell bioprinting: micropatterning tools for organ-on-chip development

Organs-On-Chips and Its Applications

A novel organ-chip system emulates three-dimensional architecture of the human epithelia and the mechanical forces acting on it

From 3D cell culture to organs-on-chips

Advances and challenges in organ-on-chip technology: toward mimicking human physiology and disease in vitro

Organ-on-chip technology: Opportunities and challenges

Organoid-on-a-chip: Current challenges, trends, and future scope toward medicine

Organs-on-chips technologies - A guide from disease models to opportunities for drug development

Review: 3D cell models for organ-on-a-chip applications

Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development

Engineered Vasculature for Organ-on-a-Chip Systems